Endothelial-derived FGF2 contributes to the progression of pulmonary hypertension in humans and rodents. - Wikidata - awgldk - TriplyDB

Endothelial-derived FGF2 contributes to the progression of pulmonary hypertension in humans and rodents.

Endothelial-derived FGF2 contributes to the progression of pulmonary hypertension in humans and rodents.

http://www.wikidata.org/entity/Q37111334

about

Apelin-APJ signaling: a potential therapeutic target for pulmonary arterial hypertension Novel signaling pathways in pulmonary arterial hypertension (2015 Grover Conference Series)Short-term exposure to engineered nanomaterials affects cellular epigenome Rapidly acquired resistance to EGFR tyrosine kinase inhibitors in NSCLC cell lines through de-repression of FGFR2 and FGFR3 expression.The cancer theory of pulmonary arterial hypertension.Key role of the endothelial TGF-β/ALK1/endoglin signaling pathway in humans and rodents pulmonary hypertension.Prenatal programming of pulmonary hypertension induced by chronic hypoxia or ductal ligation in sheep Phosphodiesterase 10A upregulation contributes to pulmonary vascular remodeling Inflammation and immunity in the pathogenesis of pulmonary arterial hypertension Fetal production of growth factors and inflammatory mediators predicts pulmonary hypertension in congenital diaphragmatic hernia.Transgenic expression of nonclassically secreted FGF suppresses kidney repair.An endothelial apelin-FGF link mediated by miR-424 and miR-503 is disrupted in pulmonary arterial hypertension The myriad essential roles of microRNAs in cardiovascular homeostasis and disease.Delineating the angiogenic gene expression profile before pulmonary vascular remodeling in a lamb model of congenital heart disease.Elevated FGF23 levels are associated with impaired calcium-mediated suppression of PTH in ESRD.Circulating endothelial cells in refractory pulmonary hypertension in children: markers of treatment efficacy and clinical worsening.Pathway analysis shows association between FGFBP1 and hypertension.New perspectives for the treatment of pulmonary hypertension Restoration of impaired endothelial myocyte enhancer factor 2 function rescues pulmonary arterial hypertension.The beneficial effect of suramin on monocrotaline-induced pulmonary hypertension in rats Metabolomic heterogeneity of pulmonary arterial hypertension CXCR4 inhibition ameliorates severe obliterative pulmonary hypertension and accumulation of C-kit⁺ cells in rats Hyperplastic Growth of Pulmonary Artery Smooth Muscle Cells from Subjects with Pulmonary Arterial Hypertension Is Activated through JNK and p38 MAPK.Update on pulmonary hypertension 2009.Loss-of-function thrombospondin-1 mutations in familial pulmonary hypertension Regulation of Cell Cycle Regulators by SIRT1 Contributes to Resveratrol-Mediated Prevention of Pulmonary Arterial Hypertension.Dramatic response to inhaled dobesilate in a patient with lung squamous cell cancer.Vascular endothelial cell-specific microRNA-15a inhibits angiogenesis in hindlimb ischemia.Gene therapy by targeted adenovirus-mediated knockdown of pulmonary endothelial Tph1 attenuates hypoxia-induced pulmonary hypertension.Vascular Cells in Blood Vessel Wall Development and Disease.Inhibition of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) reverses experimental pulmonary hypertension.mTOR and vascular remodeling in lung diseases: current challenges and therapeutic prospects.Autocrine fibroblast growth factor-2 signaling contributes to altered endothelial phenotype in pulmonary hypertension.Mechanics and mechanisms of pulmonary hypertension-Conference summary and translational perspectives.Rapamycin reverses pulmonary artery smooth muscle cell proliferation in pulmonary hypertension Intrinsic FGF2 and FGF5 promotes angiogenesis of human aortic endothelial cells in 3D microfluidic angiogenesis system.MicroRNAs in pulmonary arterial remodeling Dysregulated renin-angiotensin-aldosterone system contributes to pulmonary arterial hypertension A critical role for p130Cas in the progression of pulmonary hypertension in humans and rodents.Tie2-mediated loss of peroxisome proliferator-activated receptor-gamma in mice causes PDGF receptor-beta-dependent pulmonary arterial muscularization.

P2860

Q27010531-66763456-A2F9-4E91-A12D-8A05FA3F4F81 Q28078976-C8DCC12F-C39F-4A13-8F80-EEE2017D3503 Q28393194-6E562272-3066-4F50-B0A0-FF16A49B2588 Q33770265-C25A1EC2-BF0D-481B-A27C-042D10D9EBDD Q33788493-F22AA615-B611-404A-B915-6D47688CF565 Q33793407-72F7A94B-EEEF-4BCE-A7BE-7C2AA6D85089 Q33806234-D6B6B982-FED3-45FB-A41D-68CB342A7292 Q33873485-A7AD311B-E2D3-4597-BC6D-698BFC9D3F81 Q33898213-D0E83482-E6DD-4DB4-90EF-726E20D31ADF Q34182389-E195687D-127C-4F03-8601-5C0535D3577F Q34273599-C29F5A2F-947F-4E84-BA84-A5A4279DD524 Q34319305-F0A05819-E510-4381-83FC-15BC0AD601B6 Q34356918-7092E390-A80A-4124-917B-BA44A4792E30 Q34518898-EDC79C25-D4B7-481B-9F63-D4962CBF67A7 Q34571776-C1E1DA5B-0937-4018-B111-BED5A1CE0EA2 Q34769618-78261E3F-890F-4F8B-805D-0DE74DA637AA Q34870845-4C389F20-DCAE-4770-966D-01319AE60E4C Q34903204-46DAF0DB-7C4D-4560-9F2B-0A985968016F Q34945488-5BE1B115-511B-4497-AC4E-5E0883EEDACE Q35021663-BC9010A8-DD31-41EE-B652-1D194F2B6454 Q35095550-269DBB36-4C9A-4549-9A84-D6B98CF0F28C Q35108148-98CDF5C2-160B-4975-A250-1A3501A56676 Q35533008-A60D91BA-C554-4EEA-A4B6-B9FB1D62D5A6 Q35716098-3047289F-664E-439E-8440-73944A3A2527 Q35850320-9C5561C6-6DE9-43BA-9C96-E14160D9CFE2 Q35930978-5866FC6A-1295-4533-8FC3-535AA3610125 Q35979621-9C692B68-2325-4E21-AE01-7FC4447C4800 Q36137478-9C75CEB2-009A-40FC-B88B-C374C3811175 Q36142458-FC8BDBA8-7124-493B-A9FD-0E6EDA5A8C4F Q36284522-5097F368-E0C5-41ED-B3D7-416A1E3BE8DF Q36340848-BC50D45D-1F17-4A7B-9F8E-E68FDD7412C1 Q36788720-38B98623-B930-4D37-8783-3C37DE9BE38F Q36805200-47B7BA21-925D-4145-8498-60AD6A932D78 Q36810785-0D20686E-0876-4DB2-AF6E-96EF9F623B04 Q36990317-8BF2C39B-BA85-4AE0-9285-BE6227BB2A83 Q37054315-40221F30-ED27-4700-9F1E-76FD092894CE Q37308092-FB8DF8BA-2319-4BE2-881D-EB4E87D7B25C Q37408132-EAE65EF0-1A54-4D0D-B39A-425BAC7E5E95 Q37410202-B65FC985-CD60-424D-9264-7F24E9DC3EEE Q37474984-3825E4DE-A603-44FE-B34A-9396AB2F8342

P2860

Endothelial-derived FGF2 contributes to the progression of pulmonary hypertension in humans and rodents.

http://www.wikidata.org/entity/Q37111334

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 09 February 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Endothelial-derived FGF2 contr ...... tension in humans and rodents.

@en

Endothelial-derived FGF2 contr ...... tension in humans and rodents.

@nl

type

label

Endothelial-derived FGF2 contr ...... tension in humans and rodents.

@en

Endothelial-derived FGF2 contr ...... tension in humans and rodents.

@nl

prefLabel

Endothelial-derived FGF2 contr ...... tension in humans and rodents.

@en

Endothelial-derived FGF2 contr ...... tension in humans and rodents.

@nl

P1433

Q37111334-35616D89-65DC-4BD6-A0E6-503D41CF4A7A

P1476

Q37111334-13734597-355D-4700-B230-E72E62BA81CF

P2093

Q37111334-361F204A-C645-4FB4-840F-9C5B6CF13A93

Q37111334-5EA38A8E-500F-4F66-9ECF-BA6D4578144E

Q37111334-809E1FE1-9E86-43EA-B58C-656246EEB13E

Q37111334-80C14891-B341-4967-A4B0-50F697A94E22

Q37111334-AC4F0FEB-61E4-42F0-9CE4-0A3DFDAFF902

Q37111334-AD27F4B7-2992-4ED9-B7D4-4E5BDD6C161E

Q37111334-B9CA43B8-67CC-4480-8904-8D3E6C649678

Q37111334-ED67DD74-95EA-455B-B015-C2144D29DFCF

Q37111334-EF550A97-8179-46A3-AF24-78A1367EE41B

Q37111334-F8243E0A-0A00-4BD8-B153-DF586F30C30A

P2860

Q37111334-14A89384-2200-4425-8917-C1BECE8B8B11

Q37111334-1F3E9AF9-47A9-43A2-BCE8-9D3B631C3F0A

Q37111334-2CD214DD-89CD-4475-8EFA-739050699B27

Q37111334-2F64768C-5773-44FF-BBB0-E9E86FDC70FF

Q37111334-36558150-811E-4DCE-9715-3F52A34F3A64

Q37111334-3710B75C-F6B2-491B-B986-4E09504D551C

Q37111334-3F76389F-B12A-48C2-9A54-7D7F3766026C

Q37111334-40397320-2963-4F43-AB65-C59D05493C8D

Q37111334-485C5BF3-65C7-49F6-9B06-97CC23A2D6AB

Q37111334-50A2207A-1C50-44A2-82DD-8A913785EE9F

P304

Q37111334-58331902-A56F-4AC7-9A2C-BCC9D15EA8A0

P31

Q37111334-CC513992-65EB-41D9-853E-F1A670967F99

P356

Q37111334-F8D2EDB6-50C7-4283-80E9-2204C4077D66

P407

Q37111334-756511AC-4A9C-42B9-9FBA-E88C11711534

P433

Q37111334-5CE6FD8F-B63C-419D-AE7A-0DC51ACAFE4C

P478

Q37111334-56A8FB94-E922-4223-B297-01A63840E2E7

P50

Q37111334-2D31D7B9-320A-4B2A-9653-B54D708B704C

Q37111334-3E57B806-F6BC-48A3-8AE6-A7A03F82B2AB

P577

Q37111334-3B7F6244-38AF-4A2B-A120-509842093123

P5875

Q37111334-E48709C3-F5FA-4F5C-A93E-6AFD47274371

P698

Q37111334-5C4340A1-B7BC-4CBC-9C57-47F5F6246969

P921

Q37111334-77B2946C-644E-4F08-AEC7-B1E6AB9F67E6

Q37111334-D54491B8-55A6-4C5B-9C17-056D85369071

P932

Q37111334-B12B3DDB-CC3A-4610-943F-B7FBBFAB34A1

P356

P1433

Journal of Clinical Investigation

P1476

Endothelial-derived FGF2 contr ...... tension in humans and rodents.

@en

P2093

Bernadette Raffestin

http://www.w3.org/2001/XMLSchema#string

Bernard Maitre

http://www.w3.org/2001/XMLSchema#string

Christophe Guignabert

http://www.w3.org/2001/XMLSchema#string

Elie Fadel

http://www.w3.org/2001/XMLSchema#string

Gerald Simonneau

http://www.w3.org/2001/XMLSchema#string

Ly Tu

http://www.w3.org/2001/XMLSchema#string

Mohamed Izikki

http://www.w3.org/2001/XMLSchema#string

Patricia Zadigue

http://www.w3.org/2001/XMLSchema#string

Philippe Dartevelle

http://www.w3.org/2001/XMLSchema#string

Saadia Eddahibi

http://www.w3.org/2001/XMLSchema#string

P2860

FGF-2 protects small cell lung cancer cells from apoptosis through a complex involving PKCepsilon, B-Raf and S6K2

Fibroblast growth factors, their receptors and signaling

Colocalization of neurotransmitters analyzed by in situ hybridization

Serotonin transporter overexpression is responsible for pulmonary artery smooth muscle hyperplasia in primary pulmonary hypertension

Targets of fibroblast growth factor 1 (FGF-1) and FGF-2 signaling involved in the invasive and tumorigenic behavior of carcinoma cells

Endothelial/pericyte interactions

Inhibition of fibroblast growth factor 2-induced apoptosis involves survivin expression, protein kinase C alpha activation and subcellular translocation of Smac in human small cell lung cancer cells.

Reversal of experimental pulmonary hypertension by PDGF inhibition.

Elevated levels of an angiogenic peptide, basic fibroblast growth factor, in the urine of patients with a wide spectrum of cancers.

Angiogenic growth factors: autocrine and paracrine regulation of survival in hematologic malignancies.

P304

512-523

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI35070

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

119

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-02-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23983496

http://www.w3.org/2001/XMLSchema#string

P698

19197140

http://www.w3.org/2001/XMLSchema#string

P921

arterial hypertension

P932

2648677

http://www.w3.org/2001/XMLSchema#string